Large-scale testing (Phase 3)Study completedNCT00481767
What this trial is testing
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
Who this might be right for
Human Papillomavirus (HPV) Infection
GlaxoSmithKline 676